Wei Zhao
Pediatrics · Richmond, VANPI 1669587929
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 55 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 24.6% of the total. 2025 is the largest year on record at $1,583, 7.3 times the $216 reported in 2019. Among pediatrics clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 55 payments — averaging $83.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$1K
- AstraZeneca$1K
- GSK$686
- Blueprint Medicines Corporation$291
- Greer Laboratories, Inc.$175
- Biocryst US Sales Co., LLC$168
- plus $1K from 15 others
What the payments were for
- Food & beverage$4,566100%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $1,127 |
| AstraZeneca | 12 | $1,091 |
| GSK | 8 | $686 |
| Blueprint Medicines Corporation | 4 | $291 |
| Greer Laboratories, Inc. | 1 | $175 |
| Biocryst US Sales Co., LLC | 2 | $168 |
| Genentech USA, Inc. | 1 | $143 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $123 |
| Sanofi | 1 | $121 |
| Pfizer | 1 | $120 |
| Neurelis, Inc. | 1 | $111 |
| Pharming Healthcare, Inc. | 1 | $100 |
| Merck | 1 | $75 |
| Ionis Pharmaceuticals, Inc. | 1 | $50 |
| Idorsia Pharmaceuticals US Inc | 2 | $41 |
| Aimmune Therapeutics, Inc. | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Calliditas Therapeutics US Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $24 |
| Dexcom, Inc. | 1 | $20 |
| Hikma Pharmaceuticals USA | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,575 in reported general payments places this provider in the 95th percentile of 1,542 pediatrics providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pediatrics in Richmond
- Dominick PastoreRichmond$1.1M
- Anne Marie IraniRichmond$265K
- Marcus CardenRichmond$4K
- Valre WelchRichmond$4K
- Ashley PerryRichmond$4K
- Donna MitchellRichmond$4K
- Stephanie PocsikRichmond$3K
- Patricia MulreanyMidlothian$1.5M
- Judith GrossbergMidlothian$291K
- Elizabeth CullenMidlothian$289K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.